Suppr超能文献

腺嘌呤磷酸核糖转移酶(APRT)缺乏症

[Adenine phosphoribosyltransferase(APRT) deficiency].

作者信息

Kamatani N

机构信息

Institute of Rheumatology, Tokyo Women's Medical College.

出版信息

Nihon Rinsho. 1996 Dec;54(12):3321-7.

PMID:8976113
Abstract

Adenine phosphoribosyltransferase(APRT) deficiency is an autosomal recessive disorder and the homozygotes develop 2,8-dihydroxyadenine(DHA) urolithiasis and, in severe cases, renal failure. The prevalence is higher among the Japanese than other ethnic groups. So far 120 cases have been reported among the Japanese. The disease is classified into 2 types; type I and II are associated with complete and partial deficiencies, respectively. While all non-Japanese cases were of type I, about 78% of the Japanese patients were of type II. Each of the type II patients has at least one APRTJ allele with a ATG(Met) to ACG(Thr) base substitution at codon 136. All APRTJ alleles were derived from a single ancestor. All type I patients and some type II patients possess APRT*QO alleles with various point mutations or large gene abnormality. Type II patients tend to develop first symptoms later than the type I patients. The diagnoses of homozygotes and heterozygotes can be done by the cell culture methods. Both enzyme assay and molecular diagnostic methods are useful but not as reliable as the cell culture methods Excessive water intake, restriction of foods with high adenine contents and administration of allopurinol are useful treatments.

摘要

腺嘌呤磷酸核糖转移酶(APRT)缺乏症是一种常染色体隐性疾病,纯合子会发展为2,8 - 二羟基腺嘌呤(DHA)尿路结石,严重时会导致肾衰竭。日本人中的患病率高于其他种族。迄今为止,日本已报告120例该病例。该疾病分为2型;I型和II型分别与完全缺乏和部分缺乏相关。所有非日本病例均为I型,而约78%的日本患者为II型。II型患者中的每一个都至少有一个APRTJ等位基因,其在密码子136处存在从ATG(甲硫氨酸)到ACG(苏氨酸)的碱基替换。所有APRTJ等位基因都源自单一祖先。所有I型患者和一些II型患者拥有带有各种点突变或大基因异常的APRT*QO等位基因。II型患者往往比I型患者出现首发症状的时间晚。纯合子和杂合子的诊断可通过细胞培养方法进行。酶测定和分子诊断方法都有用,但不如细胞培养方法可靠。大量饮水、限制高腺嘌呤含量食物的摄入以及服用别嘌呤醇都是有效的治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验